Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
Top Cited Papers
Open Access
- 13 April 2000
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (15) , 1069-1076
- https://doi.org/10.1056/nejm200004133421501
Abstract
We conducted a randomized trial in which we compared high-dose chemotherapy plus hematopoietic stem-cell rescue with a prolonged course of monthly conventional-dose chemotherapy in women with metastatic breast cancer.Keywords
This publication has 17 references indexed in Scilit:
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.Journal of Clinical Oncology, 1997
- Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.Journal of Clinical Oncology, 1997
- High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.Journal of Clinical Oncology, 1997
- Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1996
- High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.Journal of Clinical Oncology, 1995
- High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.Journal of Clinical Oncology, 1992
- High-Dose Chemotherapy With Reinfusion of Purged Autologous Bone Marrow Following Dose-Intense Induction as Initial Therapy for Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Interim Analyses: The Repeated Confidence Interval ApproachJournal of the Royal Statistical Society Series B: Statistical Methodology, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988